ENCORE, a randomized, controlled, open-label non-inferiority study comparing eliglustat to imiglucerase in Gaucher disease type 1 patients stabilized on enzyme replacement therapy: 24-month results (2015)
Attributed to:
Gene Therapy for Tay-Sachs and Sandhoff diseases
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ymgme.2014.12.058
Publication URI: http://dx.doi.org/10.1016/j.ymgme.2014.12.058
Type: Journal Article/Review
Parent Publication: Molecular Genetics and Metabolism
Issue: 2
ISSN: 1096-7192